Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™
Quantum-Si (Nasdaq: QSI) has launched the Platinum Library Prep Kit, V2, an advanced tool for single-molecule protein sequencing. The new kit offers significant improvements in accessibility and efficiency, reducing hands-on preparation time to under two hours while maintaining precision. Key features include:
- 85% success rate in generating libraries and sequencing results
- Requires fivefold less protein input than V1
- Compatible with standard lab equipment
- Optimized for various protein conditions
The innovation aims to make Next-Gen Protein Sequencing™ more accessible to research labs using QSI's benchtop instrument.
Quantum-Si (Nasdaq: QSI) ha lanciato il Platinum Library Prep Kit, V2, uno strumento avanzato per la sequenziazione delle proteine a singola molecola. Il nuovo kit offre miglioramenti significativi in termini di accessibilità ed efficienza, riducendo il tempo di preparazione manuale a meno di due ore, mantenendo comunque la precisione. Le caratteristiche principali includono:
- Tasso di successo dell'85% nella generazione di librerie e nei risultati di sequenziazione
- Richiede un input di proteine cinque volte inferiore rispetto a V1
- Compatibile con attrezzature da laboratorio standard
- Ottimizzato per varie condizioni proteiche
L'innovazione mira a rendere la Next-Gen Protein Sequencing™ più accessibile ai laboratori di ricerca che utilizzano lo strumento da banco di QSI.
Quantum-Si (Nasdaq: QSI) ha lanzado el Platinum Library Prep Kit, V2, una herramienta avanzada para la secuenciación de proteínas a molécula única. El nuevo kit ofrece mejoras significativas en accesibilidad y eficiencia, reduciendo el tiempo de preparación manual a menos de dos horas mientras mantiene la precisión. Las características clave incluyen:
- Tasa de éxito del 85% en la generación de bibliotecas y resultados de secuenciación
- Requiere cinco veces menos entrada de proteína que V1
- Compatible con equipos de laboratorio estándar
- Optimizado para diversas condiciones de proteínas
La innovación tiene como objetivo hacer que la Next-Gen Protein Sequencing™ sea más accesible para los laboratorios de investigación que utilizan el instrumento de banco de QSI.
Quantum-Si (Nasdaq: QSI)는 단일 분자 단백질 시퀀싱을 위한 고급 도구인 Platinum Library Prep Kit, V2를 출시했습니다. 새로운 키트는 접근성과 효율성에서 상당한 개선을 제공하며, 수작업 준비 시간을 2시간 미만으로 줄이면서도 정밀도를 유지합니다. 주요 기능은 다음과 같습니다:
- 라이브러리 생성 및 시퀀싱 결과에서 85%의 성공률
- V1보다 단백질 입력량이 5배 적게 필요
- 표준 실험실 장비와 호환 가능
- 다양한 단백질 조건에 최적화됨
이 혁신은 QSI의 벤치탑 기기를 사용하는 연구실이 Next-Gen Protein Sequencing™을 보다 쉽게 접근할 수 있도록 하는 것을 목표로 합니다.
Quantum-Si (Nasdaq: QSI) a lancé le Platinum Library Prep Kit, V2, un outil avancé pour le séquençage de protéines à molécule unique. Le nouveau kit offre des améliorations significatives en termes d'accessibilité et d'efficacité, réduisant le temps de préparation manuel à moins de deux heures tout en maintenant la précision. Les caractéristiques clés incluent :
- Taux de réussite de 85 % pour la génération de bibliothèques et les résultats de séquençage
- Nécessite cinq fois moins d'entrée en protéine que V1
- Compatible avec les équipements de laboratoire standard
- Optimisé pour diverses conditions protéiques
Cette innovation vise à rendre le Next-Gen Protein Sequencing™ plus accessible aux laboratoires de recherche utilisant l'instrument de table de QSI.
Quantum-Si (Nasdaq: QSI) hat das Platinum Library Prep Kit, V2 auf den Markt gebracht, ein fortschrittliches Werkzeug für die Einzelmolekül-Proteinsequenzierung. Das neue Kit bietet erhebliche Verbesserungen in Bezug auf Zugänglichkeit und Effizienz, indem die manuelle Vorbereitungszeit auf unter zwei Stunden reduziert wird, während die Präzision erhalten bleibt. Zu den Hauptmerkmalen gehören:
- Erfolgsquote von 85 % bei der Generierung von Bibliotheken und Sequenzierungsergebnissen
- Benötigt fünfmal weniger Proteineingang als V1
- Kompatibel mit standardmäßiger Laborausrüstung
- Optimiert für verschiedene Proteinbedingungen
Die Innovation zielt darauf ab, die Next-Gen Protein Sequencing™ für Forschungs-Labore, die das Tischgerät von QSI verwenden, zugänglicher zu machen.
- 85% success rate in protein library generation and sequencing
- 5x reduction in required protein input compared to previous version
- Reduced hands-on preparation time to under 2 hours
- None.
Insights
The launch of Quantum-Si's enhanced Platinum Library Prep Kit V2 represents a notable technical advancement in protein sequencing technology. The key improvements include 85% protein library generation success rate and a 5x reduction in required protein input, which significantly enhances the kit's utility for precious clinical samples and challenging research applications.
The streamlined workflow reducing hands-on time to under 2 hours addresses a major pain point in proteomics research. This efficiency gain could accelerate research timelines and reduce labor costs for laboratories. The compatibility with standard lab equipment also lowers the barrier to entry for protein sequencing technology.
However, while these improvements are technically significant, the immediate revenue impact may be modest as the company works to expand its installed instrument base and drive adoption in the proteomics research market. The product enhancement demonstrates QSI's continued innovation but needs to be viewed in the context of the company's overall commercialization progress.
The new kit is designed to deliver significant advancements in accessibility and efficiency, offering researchers a streamlined library preparation process that reduces hands-on time to under two hours while maintaining precision and reliability.
Key features include:
-
Improved Performance:
85% of proteins attempted generated successful libraries and sequencing results, expanding protein diversity for deeper proteomic studies - Enhanced Workflow: Optimized for a variety of protein conditions, using fivefold less protein input than V1 making it ideal for limited or precious samples
- Simplified Preparation: Produces sequencing-ready libraries using standard lab equipment with less than two hours of hands-on time
“Our new Library Prep Kit sets the standard for accessibility in proteomics, making Next-Gen Protein Sequencing™ even more accessible and achievable for any research lab with our benchtop instrument,” said Jeff Hawkins, President and Chief Executive Officer. “This innovation will help empower researchers to unlock deeper insights into the proteome with ease, driving breakthroughs that bring us closer to understanding the complexity of life at the molecular level.”
For more information about Quantum-Si’s innovative solutions, visit www.quantum-si.com.
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Gen Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.
Forward Looking Statements
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. The actual results of the Company may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company’s expectations with respect to future performance and development and commercialization of products and services. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside the Company’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the inability to maintain the listing of the Company’s Class A common stock on The Nasdaq Stock Market; the ability of the Company to grow and manage growth profitably and retain its key employees; the Company’s ongoing leadership transitions; changes in applicable laws or regulations; the ability of the Company to raise financing in the future; the success, cost and timing of the Company’s product development and commercialization activities; the commercialization and adoption of the Company’s existing products and the success of any product the Company may offer in the future; the potential attributes and benefits of the Company’s commercialized Platinum® protein sequencing instrument and kits and the Company’s other products once commercialized; the Company’s ability to obtain and maintain regulatory approval for its products, and any related restrictions and limitations of any approved product; the Company’s ability to identify, in-license or acquire additional technology; the Company’s ability to maintain its existing lease, license, manufacture and supply agreements; the Company’s ability to compete with other companies currently marketing or engaged in the development or commercialization of products and services that serve customers engaged in proteomic analysis, many of which have greater financial and marketing resources than the Company; the size and growth potential of the markets for the Company’s products and services, and its ability to serve those markets once commercialized, either alone or in partnership with others; the Company’s estimates regarding future expenses, future revenue, capital requirements and needs for additional financing; the Company’s financial performance; and other risks and uncertainties described under “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q and in the Company’s other filings with the SEC. The Company cautions that the foregoing list of factors is not exclusive. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241205446158/en/
Investor Contact
Jeff Keyes
Chief Financial Officer
ir@quantum-si.com
Media Contact
Katherine Atkinson, SVP, Commercial Marketing
media@quantum-si.com
Source: Quantum-Si Incorporated
FAQ
What are the key features of Quantum-Si's new Platinum Library Prep Kit V2?
How much does the Quantum-Si (QSI) Platinum V2 kit reduce protein input requirements?
What is the preparation time for Quantum-Si's (QSI) new Library Prep Kit?
